Merit Financial Group LLC Acquires 428 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Merit Financial Group LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 33.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,708 shares of the healthcare conglomerate’s stock after buying an additional 428 shares during the quarter. Merit Financial Group LLC’s holdings in UnitedHealth Group were worth $871,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Signature Estate & Investment Advisors LLC increased its position in UnitedHealth Group by 1.2% during the 1st quarter. Signature Estate & Investment Advisors LLC now owns 1,606 shares of the healthcare conglomerate’s stock valued at $820,000 after purchasing an additional 19 shares during the period. Steph & Co. increased its position in UnitedHealth Group by 1.6% during the 1st quarter. Steph & Co. now owns 1,290 shares of the healthcare conglomerate’s stock valued at $658,000 after purchasing an additional 20 shares during the period. First City Capital Management Inc. grew its position in shares of UnitedHealth Group by 1.5% during the 1st quarter. First City Capital Management Inc. now owns 1,350 shares of the healthcare conglomerate’s stock worth $688,000 after buying an additional 20 shares during the period. Griffin Asset Management Inc. grew its position in shares of UnitedHealth Group by 0.3% during the 1st quarter. Griffin Asset Management Inc. now owns 6,695 shares of the healthcare conglomerate’s stock worth $3,414,000 after buying an additional 21 shares during the period. Finally, Physicians Financial Services Inc. grew its position in shares of UnitedHealth Group by 5.2% during the 1st quarter. Physicians Financial Services Inc. now owns 424 shares of the healthcare conglomerate’s stock worth $216,000 after buying an additional 21 shares during the period. Institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Trading Up 1.1 %

UnitedHealth Group stock opened at $527.51 on Friday. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a one year low of $383.12 and a one year high of $553.29. The stock has a market capitalization of $493.42 billion, a PE ratio of 27.55, a price-to-earnings-growth ratio of 1.62 and a beta of 0.76. The business’s fifty day moving average is $528.59 and its 200 day moving average is $509.42.

UnitedHealth Group (NYSE:UNHGet Rating) last released its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 EPS for the quarter, beating the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company had revenue of $80.33 billion for the quarter, compared to analysts’ expectations of $79.68 billion. During the same period last year, the firm posted $4.70 earnings per share. UnitedHealth Group’s revenue was up 12.6% compared to the same quarter last year. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th will be issued a $1.65 dividend. This represents a $6.60 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date is Friday, September 9th. UnitedHealth Group’s dividend payout ratio is 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Dirk C. Mcmahon sold 14,715 shares of the firm’s stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $543.32, for a total value of $7,994,953.80. Following the transaction, the chief executive officer now owns 50,108 shares of the company’s stock, valued at $27,224,678.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Dirk C. Mcmahon sold 14,715 shares of the firm’s stock in a transaction dated Thursday, August 18th. The stock was sold at an average price of $543.32, for a total value of $7,994,953.80. Following the transaction, the chief executive officer now owns 50,108 shares of the company’s stock, valued at $27,224,678.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,273 shares of the firm’s stock in a transaction dated Thursday, June 23rd. The stock was sold at an average price of $499.00, for a total value of $635,227.00. Following the completion of the transaction, the executive vice president now directly owns 8,104 shares in the company, valued at approximately $4,043,896. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 140,324 shares of company stock valued at $75,086,185. 0.40% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts recently issued reports on UNH shares. Loop Capital assumed coverage on shares of UnitedHealth Group in a research report on Thursday, June 16th. They issued a “buy” rating and a $575.00 price target for the company. SVB Leerink boosted their price objective on UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Oppenheimer boosted their price objective on UnitedHealth Group from $600.00 to $610.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Mizuho lifted their target price on UnitedHealth Group from $550.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Finally, Morgan Stanley boosted their price objective on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Three analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $585.65.

UnitedHealth Group Company Profile

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.